Company: RACE
Filing Date: 2025-02-27
Form Type: 424B7
Source: 0001104659-25-017677
Chunk: 32

Company: Ferrari N.V.
Filing Date: 2025-02-27
Form: 424B7
Chunk 32
---
 are incorporated herein by reference in reliance upon such report given on the authority of such firm as experts in accounting and auditing. EXPENSES The following are the estimated expenses related to the Offerings, all of which will be paid by the Selling Securityholder:

| ​ | SEC registration fee           | ​ | ​ | ​ | $ |   513,793.42 | ​ | ​ |
| ​ | Printing expenses              | ​ | ​ | ​ | $ |        5,430 | ​ | ​ |
| ​ | Legal fees and expenses        | ​ | ​ | ​ | $ |    2,150,000 | ​ | ​ |
| ​ | Accountants’ fees and expenses | ​ | ​ | ​ | $ |      399,859 | ​ | ​ |
| ​ | Total                          | ​ | ​ | ​ | $ | 3,069,082.42 | ​ | ​ |

S-20

TABLE OF CONTENTS

### PROSPECTUS

#### Ferrari N.V.

#### Common Shares
**This prospectus relates solely to sales, from time to time, of common shares, par value €0.01 per share, of Ferrari N.V. (“common shares”). The selling shareholder, Exor N.V. (the “selling shareholder”), may offer and sell our common shares from time to time in amounts, at prices and on terms that will be determined at the time of any such offering. We will not receive any of the proceeds from the sale of common shares being sold by the selling shareholder pursuant to this prospectus.

This prospectus describes some of the general terms that may apply to our common shares. If common shares are offered pursuant to this prospectus, we will provide a prospectus supplement and attach it to this prospectus. The prospectus supplement will contain more specific information about the offering, including the number of common shares to be sold by the selling shareholder. The prospectus supplement may also add, update or change information contained in this prospectus. You should read this prospectus and the accompanying prospectus supplement, as well as the documents incorporated by reference herein or therein, carefully before you make your investment decision.

This prospectus may not be used to sell securities unless it is accompanied by a prospectus supplement.

Our common shares may be sold at fixed prices, prevailing market prices at the times of sale, prices related to the prevailing market prices, varying prices determined at the times of sale or negotiated prices. Our common shares offered by this prospectus and the accompanying prospect